Agios Pharmaceuticals | AGIO - Trade Debtors


Agios Pharmaceuticals reported $16.13M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
AbbVie USD 12.48B 110M Mar/2026
Agios Pharmaceuticals USD 16.13M 5.56M Mar/2026
Alnylam Pharmaceuticals USD 912.74M 28.78M Jun/2026
Amgen USD 10.23B 1.09B Jun/2026
Arrowhead Research USD 15.68M 203.19M Mar/2026
Astellas Pharma JPY 844.8B 83.04B Jun/2026
AstraZeneca USD 18.86B 972M Jun/2026
Bayer EUR 18.55B 4.36B Mar/2026
Biogen USD 1.79B 76.6M Mar/2026
BioMarin Pharmaceutical USD 1.06B 157.13M Jun/2026
Bristol-Myers Squibb USD 13.83B 535M Jun/2026
Daiichi Sankyo JPY 676.92B 19.03B Jun/2026
Eli Lilly USD 23.48B 2.3B Jun/2026
Exelixis USD 328.95M 42.03M Mar/2026
Gilead Sciences USD 5.06B 314M Jun/2026
GlaxoSmithKline GBP 8.07B 137M Jun/2026
Incyte USD 1.13B 73.7M Jun/2026
Ionis Pharmaceuticals USD 58.84M 15.16M Jun/2026
Merck USD 12.21B 435M Mar/2026
Moderna USD 17M 54M Jun/2026
Nektar Therapeutics USD 3.6M 1.82M Mar/2026
Novartis USD 9.85B 252M Jun/2026
Novartis USD 9.6B 2.69B Mar/2026
Pfizer USD 16.19B 19M Jun/2026
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Regeneron Pharmaceuticals USD 6.57B 834.4M Jun/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
Sarepta Therapeutics USD 393.8M 154.11M Jun/2026
Vertex Pharmaceuticals USD 2.13B 138.2M Jun/2026